PERP and breast cancer: Trastuzumab also upregulated PERP in EVs emitted by trastuzumab-sensitive breast cancer cells MCF7/Her2-18, a derivative of human breast tumor cells MCF7 producing exogenous ErbB2 [30] (Fig. 2c).